Viewing nowCombinationKetosmet Tablet 15/850 mg
Metformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.

MFDS item code 201705673 · Approved 2017.07.14 · Insurance code 671705340
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication helps patients with type 2 diabetes manage blood sugar levels more effectively when combined with diet and exercise. The two components, pioglitazone and metformin, work together to stabilize blood sugar levels. Therefore, it is suitable for individuals who have difficulties managing blood sugar and aids in diabetes treatment.
For the treatment of patients with type 2 diabetes mellitus, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding the maximum doses of each component: pioglitazone 30mg and metformin 2500mg. The initial dose of this medicine should be based on the patient's current treatment regimen. 1. Patients whose blood glucose is not adequately controlled with pioglitazone or metformin monotherapy: The dose should be based on the current dose of metformin or pioglitazone. Start with 1 tablet of this medicine daily and gradually adjust the dose after assessing the adequacy of the treatment response. 2. Patients switching from combination therapy with pioglitazone and metformin: Patients switching from combination therapy with pioglitazone and metformin to this medicine may start at their previous doses of pioglitazone and metformin. No studies have been conducted to evaluate the safety and efficacy of switching patients from other oral antihyperglycemic agents to this medicine. Any change in treatment for type 2 diabetes may affect glycemic control, so caution should be exercised and appropriate monitoring should be performed. 3. Patients with renal impairment: All dose adjustments should be based on a careful assessment of renal function. In general, elderly, debilitated, and malnourished patients should not be titrated to the maximum dose of this medicine. After this medicine is administered to a patient, or when the dose is increased, the patient must be closely monitored for adverse reactions related to fluid retention. This medicine should generally be administered in divided doses with meals to reduce gastrointestinal adverse reactions caused by metformin. Sufficient time is required to assess the adequacy of the treatment response. Ideally, the response to treatment should be assessed using glycated hemoglobin (HbA1C), which is a better indicator of long-term glycemic control than fasting plasma glucose (FPG). HbA1c reflects blood glucose levels over the preceding 2 - 3 months. In clinical use of this medicine, if glycemic control measured by FPG does not worsen, administration for an appropriate period (8-12 weeks) to assess changes in HbA1C is recommended.
This medication consists of two components, with the first component being a drug that helps lower blood sugar levels. This medication should not be used in patients with impaired kidney function or liver dysfunction, severe heart failure, those with bladder cancer, and in pregnant or breastfeeding women. Additionally, it should be discontinued in cases of acute renal failure, serious infections, severe trauma, and pre- or post-surgical states. This medication can cause a rare but serious side effect known as lactic acidosis. Lactic acidosis occurs when there is an excessive buildup of lactic acid in the body, which can present symptoms such as vomiting, abdominal pain, muscle pain, difficulty breathing, and weakness. If these symptoms occur, you should immediately inform your doctor and discontinue the medication. Moreover, this medication may worsen heart failure; therefore, patients with heart disease should use it with caution and should also monitor for symptoms such as weight gain or edema. It is advisable to avoid alcohol while taking this medication. Alcohol can increase the impact of the drug on lactic acid metabolism, raising the risk of side effects. If taken alongside other diabetes medications for blood sugar control, hypoglycemia may occur, so blood sugar levels should be monitored frequently, and medication dosages adjusted as necessary. Regular blood tests and kidney function tests should be conducted while taking this medication, and monitoring of vitamin B12 levels is also recommended. Furthermore, this medication may interact with certain drugs, so it's essential to inform your doctor or pharmacist about any other medications you are currently taking. If undergoing surgery or tests using contrast agents, the medication should be temporarily discontinued and resumed only after confirming normal kidney function. Elderly patients or those with compromised kidney function should particularly adjust the dosage carefully and monitor kidney function frequently. Finally, this medication has not been confirmed to be safe and effective in pediatric patients, so it is not used in children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture. The appropriate storage temperature is room temperature between 1°C and 30°C, avoiding extremely hot or cold places.
White to grayish-white oval film-coated tablets
30 tablets (10 tablets/PTP*3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
Pioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Dalim Biotech Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Metformin Hydrochloride · Pioglitazone Hydrochloride
Prescription medication · Combination
Nexpam Korea Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Ilhwa Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.